Helix Ventures

Bering Capital is a San Francisco, United States–based life sciences venture capital firm founded around 2020 that makes early- and growth-stage investments primarily in biotechnology, medical technology and healthcare-related companies; it partners with founders to identify critical problems and support portfolio growth through strategic insights, leveraging sector expertise and relationships to help transform innovative science into commercially viable businesses, with investments including Precision Pharmaceuticals, Neuvogen and other biotech ventures.